QR code

Genetic risk and clinical implications of BRCA1 and BRCA2 mutations in Turkish triple-negative breast cancer patients

Abstract Background Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Genetic mutations, particularly in BRCA1 and BRCA2, significantly influence its pathogenesis and clinical outcomes. Th...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Betul Celik Demirbas, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Zubeyde Yalniz Kayim, Ozge Pasin, Merve Cigdem Ozgel, Seref Bugra Tuncer
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer 2025-09-01
Reeks:Discover Oncology
Onderwerpen:
BRCA1 and BRCA2 mutations
Triple-negative breast cancer
Genetic predisposition
Online toegang:https://doi.org/10.1007/s12672-025-03470-7
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items